|
1 |
Implementation and evaluation of a breast cancer disease model using real-world claims data in Germany from 2010 to 2020
Dannehl, Dominik. - Freiburg : Universität, 2024
|
|
|
2 |
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 84, 2024, Nr. 05: 459-469
|
|
|
|
3 |
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 84, 2024, Nr. 02: 185-195
|
|
|
|
4 |
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
Enthalten in Senologie Bd. 21, 2024, Nr. 02: 140-150
|
|
|
5 |
Frauengesundheit - Frauenmedizin
München : Elsevier, 2023, 1. Auflage
|
|
|
|
6 |
Frauenmedizin
München : Elsevier Health Sciences, 2023
|
|
|
|
7 |
Einführung von CDK4/6-Hemmern und deren Auswirkung auf die Behandlungslandschaft bei Patientinnen mit Brustkrebs im fortgeschrittenen Stadium – Real-World-Daten aus dem PRAEGNANT-Register
Enthalten in Senologie Bd. 20, 2023, Nr. 01: 43-56
|
|
|
|
8 |
Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
Neis, Felix. - Freiburg : Universität, 2022
|
|
|
|
9 |
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 82, 2022, Nr. 10: 1055-1067
|
|
|
|
10 |
Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
Enthalten in Archives of gynecology and obstetrics 2.9.2022: 1-12
|
|
Administration
